Patients of Metastatic Prostate Cancer Could Benefit from Immunotherapy Treatment
A recent study found that a group of patients with metastatic castration-resistant prostate cancer responded positively to treatment with ipilimumab, prolonging survival after treatment in the “favorable” cohort.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news